[68Ga]Ga-FAPI PET/CT Improves the T Staging of Patients with Newly Diagnosed Nasopharyngeal Carcinoma: A Comparison with [18F]F-FDG
- PMID: 35945360
- DOI: 10.1007/s11307-022-01748-8
[68Ga]Ga-FAPI PET/CT Improves the T Staging of Patients with Newly Diagnosed Nasopharyngeal Carcinoma: A Comparison with [18F]F-FDG
Abstract
Purpose: This study aimed to explore the value of [68Ga]Ga-labelled fibroblast activation protein inhibitor ([68Ga]Ga-FAPI) positron emission tomography/computed tomography (PET/CT) in the initial staging of patients with newly diagnosed nasopharyngeal carcinoma (NPC), compared with 2-deoxy-2[18F]fluoro-D-glucose ([18F]F-FDG) PET/CT.
Materials and methods: Forty-seven treatment-naïve patients with newly diagnosed NPC underwent magnetic resonance imaging (MRI), [68Ga]Ga-DOTA-FAPI-04 PET/CT and [18F]F-FDG PET/CT within 1 week. The diagnostic efficiency of all imaging modalities for evaluating primary tumour extension was compared from the two aspects of soft tissue and bony structure involvement. The accuracy of two PET/CT methods for diagnosing cervical lymph node (CLN) metastases was compared, and MRI served as the standard reference. T and N stages were assessed by MRI, [68Ga]Ga-FAPI PET/CT and [18F]F-FDG PET/CT. Immunohistochemical (IHC) staining for FAP was conducted in 22 of the patients.
Results: [68Ga]Ga-FAPI PET/CT outperformed [18F]F-FDG PET/CT in the assessment of primary tumour invasion in the cavernous sinus (10 vs. 1, p < 0.001) and bony structures (207 vs. 177, p < 0.001). Compared with MRI, [68Ga]Ga-FAPI PET/CT upgraded and underestimated T stage in 13 and 2 patients, while [18F]F-FDG PET/CT upgraded and underestimated T stage in 5 and 13 patients. However, [68Ga]Ga-FAPI PET/CT was inferior to [18F]F-FDG PET/CT in diagnosing positive CLNs based on the analyses of patients, neck sides, neck levels and individual nodes. [68Ga]Ga-FAPI PET/CT changed therapeutic schedules in 8 patients because of stage group changes. The presence of FAP with high quantity and intensity in cancer-associated fibroblasts (CAFs) was confirmed in all tumour specimens.
Conclusion: [68Ga]Ga-FAPI PET/CT outperformed [18F]F-FDG PET/CT in detecting the cavernous sinus and bony structure involvement of primary NPC tumours, suggesting its value in improving T staging and therapeutic regimen selection. However, the performance of [68Ga]Ga-FAPI PET/CT is less promising for N staging because it detected fewer positive CLNs than [18F]F-FDG PET/CT.
Keywords: Nasopharyngeal carcinoma; PET/CT; Tumour staging; [18F]F-FDG; [68Ga]Ga-FAPI.
© 2022. The Author(s), under exclusive licence to World Molecular Imaging Society.
Similar articles
-
Clinical utility of [68Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma.Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3606-3617. doi: 10.1007/s00259-021-05336-w. Epub 2021 Apr 1. Eur J Nucl Med Mol Imaging. 2021. PMID: 33792760
-
Accurate preoperative staging with [68Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET/CT.Eur Radiol. 2022 Sep;32(9):6070-6079. doi: 10.1007/s00330-022-08686-7. Epub 2022 Mar 30. Eur Radiol. 2022. PMID: 35352157
-
A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study.Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3228-3237. doi: 10.1007/s00259-021-05255-w. Epub 2021 Feb 20. Eur J Nucl Med Mol Imaging. 2021. PMID: 33609152
-
Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.Theranostics. 2023 Aug 21;13(13):4694-4710. doi: 10.7150/thno.88335. eCollection 2023. Theranostics. 2023. PMID: 37649615 Free PMC article.
-
[68Ga]Ga-FAPI-04 PET MRI/CT in the evaluation of gastric carcinomas compared with [18F]-FDG PET MRI/CT: a meta-analysis.Eur J Med Res. 2023 Jan 18;28(1):34. doi: 10.1186/s40001-023-00997-9. Eur J Med Res. 2023. PMID: 36653862 Free PMC article.
Cited by
-
The comparative utility of FAPI-based PET radiotracers over [18F]FDG in the assessment of malignancies.Am J Nucl Med Mol Imaging. 2024 Aug 25;14(4):190-207. doi: 10.62347/JXZI9315. eCollection 2024. Am J Nucl Med Mol Imaging. 2024. PMID: 39309420 Free PMC article. Review.
-
Perineural spread evaluation of cranial nerves in nasopharyngeal carcinoma: superiority and reliability of isovolumetric MR imaging.Front Oncol. 2024 Nov 29;14:1492465. doi: 10.3389/fonc.2024.1492465. eCollection 2024. Front Oncol. 2024. PMID: 39678500 Free PMC article.
-
The clinical value of FAPI PET/CT in delineating target volumes for nasopharyngeal carcinoma.Eur J Nucl Med Mol Imaging. 2025 May 31. doi: 10.1007/s00259-025-07347-3. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 40447840
-
A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study.Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3386-3399. doi: 10.1007/s00259-024-06744-4. Epub 2024 May 10. Eur J Nucl Med Mol Imaging. 2024. PMID: 38724654 Clinical Trial.
-
Head-to-head comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the evaluation of tonsil cancer and lymph node metastases: a single-centre retrospective study.Cancer Imaging. 2024 May 3;24(1):56. doi: 10.1186/s40644-024-00699-3. Cancer Imaging. 2024. PMID: 38702821 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous